Joan Connolly

Chief Tech/Sci/R&D Officer at ENGENE THERAPEUTICS INC.

Net worth: - $ as of 30/06/2026

57 year

4 connections

Health Technology

Consumer Services

Commercial Services

Profile

Joan Connolly is currently Chief Technology Officer at enGene Therapeutics, Inc. since 2024.
Formerly, Ms. Connolly was Chief Technology Officer at Albireo Pharma, Inc. from 2021 to 2023 and Senior Vice President-Technical Operations at Stemline Therapeutics, Inc. Education includes an undergraduate degree from Queen's University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ENGENE THERAPEUTICS INC. -.--%	16/06/2026	0 ( -.--% )	- $	30/06/2026

Joan Connolly active positions

Companies	Position	Start
ENGENE THERAPEUTICS INC.	Chief Tech/Sci/R&D Officer	21/10/2024

All active positions of Joan Connolly

Former positions of Joan Connolly

Companies	Position	End
ALBIREO PHARMA, INC.	Chief Tech/Sci/R&D Officer	01/01/2023
STEMLINE THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	-

See the detail of Joan Connolly's experience

Training of Joan Connolly

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joan Connolly's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Stemline Therapeutics, Inc. Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics	Health Technology
Queen's University Queen's University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Albireo Pharma, Inc. Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders	Health Technology
enGene Holdings, Inc. enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines	Commercial Services